Abstract
The uterus is by far the largest female organ of the body, playing an integral role in the reproductive life of every woman. It plays a pivotal role in implantation and in absence of pregnancy, menstruation. The innermost layer of the uterus is known as tunica mucosa, popularly termed as endometrium, opposed to the outer perimetrium and median myometrium. The uterus is the only organ whose lining is almost entirely expelled and reconstructed periodically, both phenomena taking place at each ovarian cycle. With the purpose of facilitating the periodic elimination of the endometrium that undergoes regression, shrinkage, and necrosis at end of each cycle, the uterus also exhibits the unique peculiarity of physiological bleeding. The endometrial histophysiology is entirely controlled by the ovarian hormones along the cycle. Of all tissues of the human body, the endometrium is the one that, throughout the ovarian cycle, most accurately reflects the levels of estrogen and progesterone. Estradiol, produced by the ovaries on approximately day 4 or 5 of the cycle, induces growth and proliferation of the endometrium. The levels of estrogen are normally elevated during the proliferative phase of the menstrual cycle as it serves to promote proliferation of the luminal and glandular epithelial cells associated with the thickening of the endometrial lining as well as vascularization. The cessation of endometrial growth occurs before estradiol levels reach their peak and prior to the onset of progesterone production, thereby indicating that nonsteroidal factors limit the growth of endometrium. Progesterone is responsible for the secretory phase of the ovulatory cycle, and its action upon the endometrium serves two purposes. The first can be regarded as “medical.” It greatly reduces the proliferative activity of the endometrial glands, thereby preventing the appearance of endometrial hyperplasic alterations. The second is essentially “reproductive,” that is vital to create an ideal condition in the endometrium for the implantation and development of the egg.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bromer JG, Aldad TS, Taylor HS. Defining the proliferative phase endometrial defect. Fertil Steril. 2009;91(3):698–704.
Suzuki T, Sasano H, Kimura N, et al. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod. 1994;9:1589–95.
Al-Asmakh M. Reproductive function of progesterone. Middle East Fertil Soc J. 2007;12(3):147.
Swijnenburg R-J, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation. 2005;112:166–72.
Casalbore P, Budoni M, Ricci-Vitiani L, et al. Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. PLoS One. 2009;4:e4434.
Kishi Y, Tanaka Y, Shibata H, et al. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice. Cell Transplant. 2008;17:1095–102.
FriedhelmKuethe BM, Richartz CK, et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol. 2005;100:485–91.
Kumar AA, Narayanan R, Arul K, et al. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant. 2009;7:241–8.
Chen J, Zhang ZG, Li Y, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692–9.
Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
De Ugarte DA, Alfonso Z, Zuk PA, Elbarbury A. Differential expression of stem cell mobilization associated-molecules on multi lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003;89:267–70.
Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther. 2003;3:705–13.
Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–60.
Yoshitake H, Salingcarnboriboon R, Tsuji K, et al. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res. 2003;287:289–300.
Miura M, Seo BM, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004;364:149–55.
Dell’ Accio F, De Bari C, Tylzanowski P, et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928–42.
Petecchia L, Sabatini F, Tavian M, et al. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest. 2005;85:962–71.
Roberts IA, Campagnoli C, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396–402.
English A, Jones EA, Henshaw K, et al. Enumeration and phenotypic characterisation of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 2004;50:817–27.
Jia-Ling L, Tsai MS, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19:1450–6.
LeeY KJ, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007;40:75–90.
Scherjon SA, In ’t Anker PS, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102:1548–9.
Belyavski AV, Musina RA, Tarusova OV, et al. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull Exp Biol Med. 2008;145:539–43.
Gargett CE, Schwab KE, Zillwood RM, et al. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod. 2009;80:1136–45.
Jian LN, Xiang D, Zhang J, et al. Plasticity of human menstrual blood stem cells derived from the endometrium. J Zhejiang Univ-Sci B (Biomed Bitechnol). 2011;12(5):372–80.
Spencer TE, Hayashi K, Hu J, et al. Comparative developmental biology of the mammalian uterus. Curr Top Dev Biol. 2005;68:85–122.
Padykula HA, Coles LG, McCracken JA, et al. A zonal pattern of cell proliferation and differentiation in the rhesus endometrium during the estrogen surge. Biol Reprod. 1984;31(5):1103–18.
Gargett CE, Chan RWS. Label retaining cells in estrogen-induced endometrial regeneration. 4th international Society for Stem Cell Research; Toronto; 2006.
Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update. 2007;13(1):87–101.
Figueria PGM, Abrao MS, Krikun G, et al. Stem cells in endometrium and pathogenesis of endometrium. Ann N Y Acad Sci. 2011;1221(1):10–7.
Cho NH, Park YK, Kim YT, Yang H, Kim SK, et al. Lifetime expression of stem cell markers in the uterine endometrium. Fertil Steril. 2004;81:403–7.
Cui CH, Uyama T, Miyado K, et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne molecular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell. 2007;18:1586–94.
Meng X, Thomas E, Ichim JZ, et al. Endometrial regenerative cells: a novel stem cell population. J Transl Med. 2007;5:57.
Patel AN, Park E, Kuzman M, et al. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant. 2008;17:303–11.
Hida M, Nishiyama N, Miyoshi S, et al. Novel cardiac precursor- like cells from human menstrual blood- derived mesenchymal cells. Stem Cells. 2008;26:1695–704.
Gargett CE. Stem cells in gynaecology. Aust NZ J Obstet Gynaecol. 2004;44:380–6.
Chan RWS, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod. 2004;70(6):1738–50.
Gargett CE. Identification and characterization of human endometrial stem/progenitor cells. Aust N Z J Obstet Gynaecol. 2006;46:250–3.
Schwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril. 2005;84 Suppl 2:1124–30.
Goodell MA, Brose K, Paradis G, et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183(40):1797–806.
Kato K, Yoshimoto M, Kato K, et al. Characterization of side population cells in human normal endometrium. Hum Reprod. 2007;22:1214–23.
Tsuji S, Yoshimoto M, Kato K, et al. Side population cells contribute to the genesis of human endometrium. Fertil Steril. 2008;90:1528–37.
Masuda H, Matsuzaki Y, Hiratsu E, et al. Stem cell- like properties of the endomertial side population: implication in endometrial regeneration. PLoS One; 2010;5(4):e10387.
Cervello I, Gil-Sanchis C, Mas A, et al. Human endometrium side population exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One. 2010;5(6):e10964.
Cerevello I, Mas A, Gil-Sanchis C, et al. Reconstruction of endometrium from endometrial side population cells lines. PLoS One. 2011;6(6):e21221.
Ai J, Tabatabaei FS, JafarzadehKashi TS. Human endometrial adult stem cells may differentiate into odontoblast cells. Hypothesis. 2009;7(1):e6.
Ai J, Tabatabaei FS, Kajbafzedeh AM. Myogenic potential of human endometrial stem cells. Indian J Med Hypothesis Ideas. 2009;3:25.
Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod. 2007;22:2903–11.
Schwab KE, Hutchinson P, Gargett CE. Identification of surface markers for prospective isolation of human endometrial stromal colony forming cells. Hum Reprod. 2008;23:934–43.
Dimitrov R, Timeva T, Kyurchiev D. Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction. 2008;135:551–8.
Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 2003;18:696–704.
Gargett CE, Chan RWS, Schwab KE. Endometrial stem cells. Reprod Endocrinol. 2007;19(4):377–83.
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
Matthai C, Horvat R, Noe M, et al. Oct-4 expression in human endometrium. Mol Hum Reprod. 2006;12(1):7–10.
Bentz EK, Kenning M, Schneeberger C, et al. OCT-4 expression in follicular and luteal phase endometrium: a pilot study. Reprod Biol Endocrinol. 2010;8:38.
Gidekel S, Pizov G, Bergman Y, et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4(5):361–70.
Hubbard SA, Gargett CE. A cancer stem cell origin for human endometrial cancer? Reproduction. 2010;140:23–32.
Masuda H, Maruyana T, Hiratsu E, et al. Non-invasive and real time assessment of reconstructed functional human endometrium in NOD/SCID/γcnull immunodeficient mice. Proc Natl Acad Sci U S A. 2007;104(6):1925–30.
Jai ANJ, Mehrabani D. The possibility of differentiation of endometrial stem cells into neural cells. Iran Red Crescent Med J. 2010;12(3):328–31.
Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789–99.
Gazvani R, Templeton A. New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet. 2002;76:117–26.
D’ Hooghe TM, Debrock S, Meuleman C, et al. Future directions in endometriosis. Obstet Gynecol Clin North Am. 2003;30:221–44.
Starzinski-Powintz A, Zeitvogel A, Schreiner A, et al. In search of pathogenic mechanism in endometriosis: the challenge for molecular cell biology. Curr Mol Med. 2001;1:655–64.
Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann My Acad Sci. 2008;1127:106–15.
Hubbard SA, Friel AM, Kumar B, et al. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res. 2009;69:8241–8.
Friel AM, Sergent PA, Patnaude C, et al. Functional Analysis of cancer stem cell like properties of human endometrial tumor initiating cells. Cell Cycle. 2008;7:242–9.
Leyendecker G, Wildt L, Mall G. The Pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009;280:529–38.
Chen YJ, Hy L, Chang YL, et al. Suppression of migratory/invasive ability of induction and apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertil Steril. 2010. doi:10.1016/fertnstert.2010.01.070.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Indumathi, S., Dhanasekaran, M. (2015). Identity of Human Endometrial Tissue: Potent Source of Stem Cells. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-6542-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6542-2_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6541-5
Online ISBN: 978-1-4471-6542-2
eBook Packages: MedicineMedicine (R0)